Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Mar 27;12(9):853–860. doi: 10.1002/pmrj.12348

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 The Authors. PM&R published by Wiley Periodicals, Inc. on behalf of American Academy of Physical Medicine and Rehabilitation

This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Proportion of responders (≥1 grade improvement) to aboBoNT‐A based on MAS score for (A) GSC muscle tone and (B) soleus muscle tone. AboBoNT‐A, abobotulinumtoxinA; GSC, gastrocnemius‐soleus complex; MAS, Modified Ashworth Scale. *At week 12, n = 1 missing in placebo and aboBoNT‐A 1000 U groups, n = 2 missing in aboBoNT‐A 1500 U group. Data are presented for the intention‐to‐treat population. Responders were defined as patients with at least a one grade improvement in muscle tone (score on the MAS) in comparison to baseline.